Cataract differential diagnosis, investigation, management

Reading File
Finding Sources
Searching PubMed

cataract diagnosis management surgery

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Loading Image
Loading Image
I now have comprehensive information from Kanski's Clinical Ophthalmology. Let me compile the full answer.

Cataract: Differential Diagnosis, Investigation, and Management

Primary source: Kanski's Clinical Ophthalmology: A Systematic Approach, 10th ed. | Goldman-Cecil Medicine

Definition & Overview

A cataract is any opacification of the crystalline lens. It is the commonest cause of reversible visual disability in the world. There is no medical treatment to prevent its development or progression - phacoemulsification with intraocular lens (IOL) implantation is the only effective treatment and is the most commonly performed surgical procedure worldwide.

Symptoms

The effect on vision depends on the type, extent, and position of the opacity. Key symptoms include:
  • Reduced visual acuity - initially correctable with spectacles
  • Loss of contrast sensitivity
  • Change in colour perception - particularly impaired perception of blue colours
  • Glare - from light scattering; worse with posterior subcapsular types; difficulty with night driving
  • Monocular diplopia - especially with point sources of light
  • "Second sight" - paradoxical improvement in near vision in nuclear sclerotic cataract due to increased refractive index causing acquired myopia

Classification & Differential Diagnosis

A. Age-Related (Acquired) Cataract

The most common form. Three main morphological subtypes:

1. Posterior Subcapsular (PSC) Cataract

  • Granular or plaque-like opacity just in front of the posterior capsule
  • On retroillumination: appears black and vacuolated (Wedl/bladder cells)
  • Located at the nodal point - disproportionately profound effect on vision
  • Worse symptoms: glare, near vision difficulty (miosis makes it worse in bright light and near tasks)
  • Strong association with: corticosteroids, diabetes, radiation, uveitis, retinitis pigmentosa

2. Nuclear Sclerotic Cataract

  • Exaggeration of normal ageing
  • Yellowish-brown hue from urochrome pigment deposition
  • Best assessed with oblique slit-lamp beam
  • Retroillumination: good red reflex but subtle nucleus-cortex distinction
  • When advanced: brunescent (brown) or rarely black (nigra) cataract
  • Associated with acquired myopia ("second sight of the aged")

3. Cortical Cataract

  • Involves anterior, posterior, or equatorial cortex
  • Begins as clefts and vacuoles due to cortical hydration
  • Classic cuneiform (wedge-shaped) or radial spoke-like opacities
  • Often starts in the inferonasal quadrant
  • Glare is a prominent symptom

4. Christmas Tree Cataract (Uncommon)

  • Polychromatic needle-like formations in deep cortex and nucleus
  • Often associated with myotonic dystrophy

Advanced States of Maturity

StageFeatures
ImmaturePartial opacification; iris shadow seen
MatureComplete opacification; no iris shadow; white/grey appearance
HypermatureWrinkling of anterior capsule as lens shrinks
MorgagnianLiquefaction of cortex; nucleus sinks inferiorly

Age-related cataract subtypes: (A) posterior subcapsular on slit-lamp; (B) PSC on retroillumination showing Wedl cells; (C) nuclear sclerosis; (D) nuclear sclerosis on retroillumination; (E) cortical spoke-like opacities on slit-lamp; (F) cortical spokes on retroillumination; (G/H) Christmas tree cataract
Fig. 10.2 - Age-related cataract morphological types (Kanski's Clinical Ophthalmology)

B. Cataract in Systemic Disease

DiseaseCataract Type
Diabetes mellitus"Snowflake" (bilateral, rapid-onset cortical opacities in young T1DM); also early nuclear sclerosis
Myotonic dystrophyPSC spokes assuming a stellate morphology; Christmas tree; often bilateral
Atopic dermatitisShield-like anterior subcapsular opacity; 10% of severe cases; 2nd-4th decades
Neurofibromatosis type 2PSC opacity
Wilson's diseaseSunflower cataract (anterior subcapsular deposits from copper)
High myopiaPSC and early nuclear sclerosis
Galactosaemia"Oil droplet" opacity (AR, GALT enzyme deficiency)
Lowe syndromeCongenital cataract (universal); X-linked recessive
MannosidosisSpoke-like posterior cortical punctate opacities (AR)
Hypo/pseudohypoparathyroidismBilateral subcapsular opacities

Systemic disease cataracts: (A) diabetic snowflake cataract; (B) stellate PSC in myotonic dystrophy on retroillumination
Fig. 10.4B - Stellate PSC spokes in myotonic dystrophy (retroillumination) (Kanski's)

C. Secondary (Complicated) Cataract

Caused by other ocular disease:
  • Uveitis - anterior plaque opacities; extensive posterior synechiae
  • Glaucoma - Glaukomflecken: anterior subcapsular grey-white opacities after acute angle-closure attack
  • Retinitis pigmentosa / Leber congenital amaurosis / Gyrate atrophy / Stickler syndrome - PSC opacity
  • Medications: systemic and topical corticosteroids (PSC); chlorpromazine (anterior star-shaped opacity)

D. Traumatic Cataract

  • Most common cause of unilateral cataract in young people
  • Penetrating trauma: direct lens capsule breach
  • Blunt trauma: classic flower-shaped opacity (Vossius ring imprint)
  • Electric shock/lightning: diffuse milky-white or multiple snowflake stellate subcapsular opacities
  • Infrared radiation ("glassblower's cataract"): true exfoliation of anterior lens capsule
  • Ionizing radiation: PSC opacity (delayed, months-years post-exposure)

E. Congenital Cataract

  • Incidence: ~3 in 10,000 live births
  • Aetiology: 1/3 systemic disease; 1/3 inherited (most commonly autosomal dominant); 1/3 unknown
  • 2/3 bilateral (cause found in ~50%); unilateral cases usually sporadic
Intrauterine infections (TORCH):
  • Rubella: pearly nuclear or diffuse bilateral opacity (~15%)
  • Toxoplasmosis: cataract + chorioretinitis
  • CMV: cataract + chorioretinitis + microcephaly
  • Varicella: cataract + microphthalmos
Metabolic causes:
  • Galactosaemia: oil-droplet opacity (reversible with dietary exclusion of galactose)
  • Lowe syndrome: universal cataract + microphakia + congenital glaucoma in 50%
  • Mannosidosis: posterior cortical spoke-like opacities

Differential Diagnosis of Leukocoria (White Pupil)

When a cataract causes leukocoria, particularly in children, always exclude:
ConditionKey differentiating features
RetinoblastomaMost urgent to exclude; irregular white pupil reflex; intraocular mass on USS/MRI
Persistent Foetal Vasculature (PFV)Unilateral; fibrovascular stalk from disc; microphthalmos
Retinopathy of prematurityHistory of prematurity; temporal retinal traction
Coats diseaseUnilateral; subretinal exudates; telangiectatic vessels
Toxocara chorioretinitisPeripheral granuloma; serology
Corneal opacity/leucomaSuperficial - on slit-lamp vs intra-lenticular
Vitreous haemorrhageAbsent red reflex; B-scan ultrasound
EndophthalmitisAcute inflammatory; painful; hypopyon

Investigation

Ophthalmic Assessment (Pre-operative)

InvestigationPurpose
Visual acuity (Snellen/LogMAR)Baseline and indication for surgery
Glare testingFunctional impact assessment
Slit-lamp biomicroscopyType, morphology, maturity of cataract
RetroilluminationBetter delineation of PSC and cortical cataracts
Dilated fundus examinationExclude posterior pole pathology (AMD, diabetic retinopathy, macular disease) that would limit visual gain
Biometry (optical/IOL Master)Axial length + keratometry for IOL power calculation
Keratometry/corneal topographyPlanning toric IOL or astigmatism correction
Specular microscopyCorneal endothelial cell count - important if Fuchs' dystrophy or prior corneal surgery
Optical coherence tomography (OCT)Macular assessment prior to surgery
B-scan ultrasoundWhen fundus view is obscured by dense cataract
Electrophysiology (ERG/VEP)Retinal function assessment in dense cataracts when no fundal view possible
Potential acuity meter / laser interferometryPredict post-operative VA when retinal view is obscured

Systemic Workup (Pre-operative)

  • Routine tests (bloods, ECG) are not required for local anaesthesia
  • If general anaesthesia planned: U&E, random blood glucose, FBC, ECG
  • Relevant medication review: alpha-blockers (intraoperative floppy iris syndrome - IFIS), anticoagulants (INR check within 72 hours), metformin (if contrast planned)

Investigation for Congenital Cataract

  • TORCH serology (rubella IgM, CMV, toxoplasma)
  • Urine for reducing substances (galactosaemia)
  • Urine amino acids (Lowe syndrome)
  • Serum galactose-1-phosphate uridyltransferase
  • Chromosomal karyotype if dysmorphic features
  • Paediatric/genetics referral

Management

Conservative (Non-Surgical) Measures

  • Refractive correction: spectacles or contact lenses may help in early cataract
  • Pupil dilation (mydriatic drops) can transiently improve vision in PSC cataracts by allowing light around the opacity
  • Lifestyle advice: increase lighting, magnification aids
  • No proven pharmacological therapy to prevent or reverse cataract

Surgical Indications

  1. Visual indications: opacity sufficient to interfere with daily activities (driving, reading, occupation)
  2. Medical indications:
    • Phacolytic glaucoma (mature cataract leaking protein causing macrophage-mediated trabecular obstruction)
    • Phacomorphic glaucoma (intumescent lens causing angle-closure)
    • Improved fundus view for monitoring/treating posterior segment disease

Surgical Options

1. Phacoemulsification with IOL Implantation (Gold Standard)

The standard procedure worldwide. Steps:
  1. Preparation: topical antiseptic (povidone-iodine 5%), draping, speculum
  2. Incisions: corneal side port + main clear corneal incision (typically temporal)
  3. Viscoelastic injection into anterior chamber
  4. Continuous curvilinear capsulorhexis (CCC): circular opening in anterior capsule
  5. Hydrodissection: fluid injection under capsule to separate nucleus from cortex
  6. Nuclear division: "Divide and conquer" (two perpendicular grooves, cracking into quadrants) or "Phaco chop" (faster, lower energy)
  7. Emulsification and aspiration of nuclear quadrants
  8. Cortex aspiration: irrigation-aspiration (I/A) handpiece
  9. IOL implantation into capsular bag
  10. Wound closure: typically self-sealing
Anaesthesia options:
  • Topical (drops/gel ± intracameral lidocaine) - most common; no akinesia
  • Sub-Tenon block - good anaesthesia, variable akinesia
  • Peribulbar block - effective anaesthesia and akinesia; avoid in long eyes (axial >25 mm)
  • General anaesthesia - children, uncooperative patients, tremor, dementia

2. Femtosecond Laser-Assisted Cataract Surgery (FLACS)

  • Laser performs incisions, CCC, and nuclear fragmentation
  • Standard phacoemulsification provides equivalent results in most studies

3. Small Incision Cataract Surgery (SICS) / Manual ECCE

  • Used in low-resource settings or very hard nuclei

Intraocular Lens (IOL) Types

IOL TypeFeature
MonofocalStandard; one focal point (usually distance); reading glasses needed
ToricCorrects pre-existing corneal astigmatism
Multifocal/Extended depth-of-focus (EDOF)Near + distance correction; may cause halos/glare
AccommodatingAttempts to restore accommodation
Light-adjustable IOLUV irradiation post-implant fine-tunes refractive power

Post-operative Care

  • Topical antibiotic + steroid drops (e.g., 4-6 weeks)
  • Review at Day 1, Week 1, 4-6 weeks
  • Refraction at ~6 weeks for spectacle prescription

Complications of Cataract Surgery

Intraoperative

  • Posterior capsular rupture with vitreous loss (<1% experienced surgeons)
  • Zonular dehiscence
  • Dropped nucleus (~0.2%)
  • IFIS (with alpha-blockers)

Early Post-operative

  • IOP spike
  • Iridocyclitis
  • Corneal oedema
  • Wound leak

Late Post-operative

  • Posterior capsular opacification (PCO): most common late complication; Elschnig pearl formation or fibrosis-type PCO; treated with Nd:YAG laser posterior capsulotomy
  • Cystoid macular oedema (CMO)
  • Retinal detachment (<1%)
  • IOL dislocation/subluxation
  • Endophthalmitis (0.1%) - most serious infectious complication

PCO Treatment (Nd:YAG Capsulotomy)

  • Indication: reduced VA or glare from PCO
  • Power: start at 1 mJ/pulse; cruciate or circumferential pattern; opening ~4-5 mm
  • Complications: IOL pitting, IOP spike, retinal detachment risk (warn myopes), CMO

Congenital Cataract Management

  • Timing is critical - amblyopia risk means surgery should not be delayed
  • Bilateral visually-significant cataracts: surgery within first weeks of life
  • Unilateral: surgery within 6-10 weeks, followed by aggressive patching of the fellow eye
  • Optical correction post-surgery (contact lenses in infants, glasses when older)
  • Amblyopia treatment (occlusion/patching) is essential

Sources: Kanski's Clinical Ophthalmology: A Systematic Approach, 10th ed., pp. 308-344; Goldman-Cecil Medicine, International Edition, p. 4131
This is a shared conversation. Sign in to Orris to start your own chat.